Edwards Lifesciences (EW)

CapEx to Revenue

3.84%

Quarterly · Period ending:

EW logo

EW CapEx to Revenue

Latest reported3.84%
EW Quarterly CapEx/Revenue (4.70% → 3.84%)
High-resolution chart · PNG

EW capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
4.8857%
4.8984%
5.127%
7.4812%
5.3659%
4.4248%
4.7009%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.